Mobile Health App for HIV/AIDS
(LPP Plus Trial)
Trial Summary
What is the purpose of this trial?
The investigative team will conduct a 2-arm randomized control trial to examine the preliminary effect of LinkPositively+ (LPP) an enhanced version of LinkPositively (LP) mobile app on improved HIV care outcomes including improved retention in HIV care, ART adherence, and viral suppression using hair sample analysis and passive electronic, medical record review, and secondarily, self-reported increased social support via activation of social support networks (i.e., assessed by utilization), self-efficacy, and utilization of ancillary support services at baseline, 3- and 6-month post enrollment. Black women living with HIV (WLHA) with a lifetime history of interpersonal violence, who have been linked to care but may have fallen out of care in the past year will be randomized 1:1 to either the LP arm or the LPP arm.
Eligibility Criteria
This trial is for Black women living with HIV who have experienced interpersonal violence and may have had gaps in their HIV care within the past year. Participants should be currently linked to some form of HIV care.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessment including needs assessment and app training
Intervention
Participants receive the LinkPositively or LinkPositively+ intervention, including app usage and mindfulness sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- LP
- LPP+
LP is already approved in United States for the following indications:
- Improving HIV care outcomes among Black women affected by interpersonal violence and mental health issues
Find a Clinic Near You
Who Is Running the Clinical Trial?
Guiding Right, Inc.
Lead Sponsor
University of California, San Diego
Collaborator